Post by
biorun on May 04, 2023 10:54am
Recent financing raise -clue?
They were out of money, did a financial debenture, two things come to mind:
1) the significant investment by the CEO (call it greed or smoke signal)
2) they specifically said only 1/3 is for corporate burn. We know they need a lot more than that to keep lights on, so do they expect an injection from either milestone payment signalling product launch on 1067 agreement with AbbVie, a new deal with upfront payment or a non diluted research funding support from French Government?
These points have me wondering for sure.